Sangamo Therapeutics Ownership 2024 | Who Owns Sangamo Therapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

46.87%

Insider Ownership

2.28%

Retail Ownership

50.85%

Institutional Holders

119.00

Sangamo Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WASATCH ADVISORS LP11.14%0.04%20,090,570-41,754-0.21%7,198,451Jun 30, 2024
ARMISTICE CAPITAL, LLC7.80%0.06%14,060,000-2,898,477-17.09%5,037,698Jun 30, 2024
VANGUARD GROUP INC6.60%0.00%11,898,417-301,951-2.47%4,263,202Jun 30, 2024
BLACKROCK INC.2.61%-4,702,938-8,574,699-64.58%1,685,063Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.53%0.01%4,560,770-382,490-7.74%1,633,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.29%0.00%4,126,5771,528,60058.84%1,478,553Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC1.64%0.00%2,950,9442,758,9951437.36%1,057,323Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.34%0.00%2,408,1971,303,320117.96%862,857Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.03%0.00%1,866,186-1,497,605-44.52%668,796Jun 30, 2024
GOLDMAN SACHS GROUP INC0.74%0.00%1,333,454700,826110.78%477,776Jun 30, 2024
NORTHERN TRUST CORP0.67%0.00%1,201,047-27,838-2.27%430,335,000Jun 30, 2024
D. E. SHAW & CO., INC.0.65%0.00%1,165,993-1,901,442-61.99%417,776Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC0.61%0.02%1,098,000--393,413Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.58%0.00%1,046,201-195,930-15.77%374,854Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.52%0.02%933,176568,892156.17%334,000Jun 30, 2024
HIGHTOWER ADVISORS, LLC0.44%0.00%792,3134,0230.51%255,000Jun 30, 2024
MORGAN STANLEY0.43%-781,397247,32646.31%279,974Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.41%0.01%744,102744,102100.00%266,612Jun 30, 2024
MARSHALL WACE, LLP0.32%0.00%576,219207,47656.27%207,439Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.30%0.00%543,194-11,661-2.10%194,626Jun 30, 2024

Sangamo Therapeutics's largest institutional shareholder is WASATCH ADVISORS LP, holding 11.14% of the company's total share outstanding, currently valued at $7.20M. The top 10 institutional shareholders own together 37.71% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARMISTICE CAPITAL, LLC7.80%0.06%14,060,000-2,898,477-17.09%5,037,698Jun 30, 2024
WASATCH ADVISORS LP11.14%0.04%20,090,570-41,754-0.21%7,198,451Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.52%0.02%933,176568,892156.17%334,000Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.14%0.02%247,866247,866100.00%88,810Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC0.61%0.02%1,098,000--393,413Jun 30, 2024
GOLDEN STATE EQUITY PARTNERS0.11%0.01%197,116197,116100.00%70,627Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.41%0.01%744,102744,102100.00%266,612Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.53%0.01%4,560,770-382,490-7.74%1,633,000Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC1.64%0.00%2,950,9442,758,9951437.36%1,057,323Jun 30, 2024
SANDBOX FINANCIAL PARTNERS, LLC0.01%0.00%24,833--8,898Jun 30, 2024
LJI WEALTH MANAGEMENT, LLC0.02%0.00%36,160-4,100-10.18%12,956Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.29%0.00%4,126,5771,528,60058.84%1,478,553Jun 30, 2024
FOUNDERS CAPITAL MANAGEMENT0.01%0.00%10,000--3,583Jun 30, 2024
CENTIVA CAPITAL, LP0.17%0.00%308,500308,500100.00%110,536Jun 30, 2024
UNIQUE WEALTH, LLC0.01%0.00%16,40016,400100.00%6,783Jun 30, 2024
MERITAGE PORTFOLIO MANAGEMENT0.04%0.00%78,260--28,000Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.02%0.00%41,1356,50018.77%14,739Jun 30, 2024
FORT SHERIDAN ADVISORS LLC0.01%0.00%21,821-200-0.91%7,818Jun 30, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.0.01%0.00%11,083-155-1.38%6,021Jun 30, 2024
XTX TOPCO LTD0.02%0.00%38,73512,71148.84%13,879Jun 30, 2024

The largest Sangamo Therapeutics shareholder by % of total assets is ARMISTICE CAPITAL, LLC. The company owns 14.06M shares of Sangamo Therapeutics (SGMO), representing 0.06% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JACOBS LEVY EQUITY MANAGEMENT, INC1.64%0.00%2,950,9442,758,9951437.36%1,057,323Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC2.29%0.00%4,126,5771,528,60058.84%1,478,553Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.34%0.00%2,408,1971,303,320117.96%862,857Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.41%0.01%744,102744,102100.00%266,612Jun 30, 2024
GOLDMAN SACHS GROUP INC0.74%0.00%1,333,454700,826110.78%477,776Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.52%0.02%933,176568,892156.17%334,000Jun 30, 2024
CENTIVA CAPITAL, LP0.17%0.00%308,500308,500100.00%110,536Jun 30, 2024
HRT FINANCIAL LP0.15%0.00%264,441264,441100.00%94,000Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.14%0.02%247,866247,866100.00%88,810Jun 30, 2024
MORGAN STANLEY0.43%-781,397247,32646.31%279,974Jun 30, 2024
MARSHALL WACE, LLP0.32%0.00%576,219207,47656.27%207,439Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.11%0.00%199,788199,788100.00%71,584Jun 30, 2024
GOLDEN STATE EQUITY PARTNERS0.11%0.01%197,116197,116100.00%70,627Jun 30, 2024
GROUP ONE TRADING, L.P.0.15%0.00%268,436187,294230.82%96,181,000Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.10%0.00%185,813185,813100.00%66,577Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%74,84274,842100.00%26,816Jun 30, 2024
POINT72 (DIFC) LTD0.04%0.00%63,84063,840100.00%22,874Jun 30, 2024
AMERIPRISE FINANCIAL INC0.04%-75,27463,800556.04%26,971Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.03%0.00%57,72141,797262.48%20,664Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.02%-31,77331,773100.00%11,384Jun 30, 2024

As of Jun 30 2024, Sangamo Therapeutics's largest institutional buyer is JACOBS LEVY EQUITY MANAGEMENT, INC. The company purchased 2.76M stocks of SGMO, valued at $1.06M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.2.61%-4,702,938-8,574,699-64.58%1,685,063Jun 30, 2024
ARMISTICE CAPITAL, LLC7.80%0.06%14,060,000-2,898,477-17.09%5,037,698Jun 30, 2024
STATE STREET CORP0.29%-519,221-2,232,583-81.13%186,037,000Jun 30, 2024
D. E. SHAW & CO., INC.0.65%0.00%1,165,993-1,901,442-61.99%417,776Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.03%0.00%1,866,186-1,497,605-44.52%668,796Jun 30, 2024
JPMORGAN CHASE & CO0.00%-3,207-1,319,341-99.76%1,149Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.07%0.00%135,000-1,238,500-90.17%48,371Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----737,464-100.00%-Jun 30, 2024
ZACKS INVESTMENT MANAGEMENT0.07%0.00%128,230-579,938-81.89%45,945Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----493,431-100.00%-Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.01%-14,510-458,602-96.93%5,199Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.53%0.01%4,560,770-382,490-7.74%1,633,000Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.05%0.00%94,700-350,600-78.73%33,931Jun 30, 2024
VANGUARD GROUP INC6.60%0.00%11,898,417-301,951-2.47%4,263,202Jun 30, 2024
ALLIANCEBERNSTEIN L.P.----237,830-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----222,300-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.58%0.00%1,046,201-195,930-15.77%374,854Jun 30, 2024
BARCLAYS PLC0.03%-54,512-167,543-75.45%19,000Jun 30, 2024
RHUMBLINE ADVISERS0.03%-59,653-159,173-72.74%21,354Jun 30, 2024
BANK OF AMERICA CORP /DE/0.09%-158,231-110,829-41.19%56,647Jun 30, 2024

As of Jun 30 2024, Sangamo Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -8.57M shares of SGMO, valued at $1.69M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
Y-INTERCEPT (HONG KONG) LTD0.41%0.01%744,102744,102100.00%266,612Jun 30, 2024
CENTIVA CAPITAL, LP0.17%0.00%308,500308,500100.00%110,536Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.14%0.02%247,866247,866100.00%88,810Jun 30, 2024
GOLDEN STATE EQUITY PARTNERS0.11%0.01%197,116197,116100.00%70,627Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.10%0.00%185,813185,813100.00%66,577Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.04%0.00%74,84274,842100.00%26,816Jun 30, 2024
POINT72 (DIFC) LTD0.04%0.00%63,84063,840100.00%22,874Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.02%-31,77331,773100.00%11,384Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.02%0.00%29,62529,625100.00%10,615Jun 30, 2024
JUMP FINANCIAL, LLC0.01%0.00%26,38326,383100.00%9,453Jun 30, 2024
VICTORY CAPITAL MANAGEMENT INC0.01%-24,10024,100100.00%8,635Jun 30, 2024
PENSIONMARK FINANCIAL GROUP, LLC0.01%0.00%22,61122,611100.00%8,102Jun 30, 2024
UNIQUE WEALTH, LLC0.01%0.00%16,40016,400100.00%6,783Jun 30, 2024
OPTIVER HOLDING B.V.0.00%-3,2003,200100.00%1,147Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.00%0.00%3,0003,000100.00%1,075Jun 30, 2024
BROWN, LISLE/CUMMINGS, INC.0.00%0.00%1,5251,525100.00%546Jun 30, 2024
CWM, LLC0.00%-1,3961,396100.00%1,000Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT0.00%0.00%1,0001,000100.00%358Jun 30, 2024
US BANCORP \DE\0.00%-535535100.00%192Jun 30, 2024
ABICH FINANCIAL WEALTH MANAGEMENT LLC0.00%0.00%418418100.00%150Jun 30, 2024
SANDY SPRING BANK0.00%-400400100.00%144Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC0.00%-200200100.00%72Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%-142142100.00%51Jun 30, 2024

Sangamo Therapeutics's largest new institutional shareholder by number of shares is Y-INTERCEPT (HONG KONG) LTD, purchased 744.10K shares, valued at $266.61K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NUVEEN ASSET MANAGEMENT, LLC----737,464-100.00%-Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----493,431-100.00%-Jun 30, 2024
ALLIANCEBERNSTEIN L.P.----237,830-100.00%-Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC----222,300-100.00%-Jun 30, 2024
PRUDENTIAL FINANCIAL INC----94,236-100.00%-Jun 30, 2024
STATE OF WYOMING----75,319-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----73,421-100.00%-Jun 30, 2024
DEUTSCHE BANK AG\----62,549-100.00%-Jun 30, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM----62,345-100.00%-Jun 30, 2024
STRS OHIO----61,300-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----58,584-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----53,715-100.00%-Jun 30, 2024
MACKENZIE FINANCIAL CORP----43,920-100.00%-Jun 30, 2024
MYDA ADVISORS LLC----40,000-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----39,990-100.00%-Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE----35,760-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----23,437-100.00%-Jun 30, 2024
AXXCESS WEALTH MANAGEMENT, LLC----16,707-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----14,977-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----13,096-100.00%-Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC----11,458-100.00%-Jun 30, 2024
NEUBERGER BERMAN GROUP LLC----10,587-100.00%-Jun 30, 2024
WOLVERINE TRADING, LLC----10,200-100.00%-Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.----9,803-100.00%-Jun 30, 2024
AMALGAMATED BANK----4,874-100.00%-Jun 30, 2024
CONTINUUM ADVISORY, LLC----1,115-100.00%-Jun 30, 2024
BENJAMIN F. EDWARDS & COMPANY, INC.----850-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----507-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----500-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----285-100.00%-Jun 30, 2024
UMB BANK, N.A.----200-100.00%-Jun 30, 2024

Sangamo Therapeutics's largest sold out institutional shareholder by shares sold is NUVEEN ASSET MANAGEMENT, LLC, sold -0.74M shares, valued at -, as of undefined.

Sangamo Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Kelly Strategic ETF Trust3.74%101,500--Feb 29, 2024
WASATCH FUNDS TRUST1.91%17,689,3437,394,99771.84%Mar 31, 2024
Vanguard Montgomery Funds1.58%376,349--Mar 31, 2024
Zacks Trust0.58%53,11435,129195.32%Feb 29, 2024
SARATOGA ADVANTAGE TRUST0.51%31,1015711.87%Feb 29, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.37%71,734--Mar 28, 2024
DELAWARE GROUP EQUITY FUNDS IV0.34%400,000--Mar 28, 2024
CORNERCAP GROUP OF FUNDS /VA/0.34%24,5418,58553.80%Sep 30, 2022
REYNOLDS FUNDS INC0.17%1,900--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.17%87,322--Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.16%339,962--Feb 29, 2024
Federated Hermes MDT Series0.14%335,119-57,352-14.61%Jan 31, 2024
TEKLA HEALTHCARE INVESTORS0.12%103,856--Mar 31, 2024
Humankind Benefit Corp0.12%2,597--Dec 31, 2023
VANGUARD EXPLORER FUND0.11%1,395,270--Jan 31, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.11%66,985--Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.10%45,979--Mar 31, 2024
VANGUARD HORIZON FUNDS0.09%2,182,526-2,340,642-51.75%Mar 31, 2024
BRIDGEWAY FUNDS INC0.08%195,000-100,000-33.90%Mar 28, 2024
ROYCE VALUE TRUST, INC.0.08%65,815--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.07%288,065--Jan 31, 2024
M FUND INC0.05%23,830--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.04%254,025--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.04%20,905--Mar 31, 2024
ALGER FUNDS0.03%30,000--Jan 31, 2024
Fidelity Commonwealth Trust II0.03%177,187--Aug 31, 2023
ETFis Series Trust I0.02%29,327--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.02%235,604128,866120.73%Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%3,362--Mar 31, 2024
JNL VARIABLE FUND LLC0.01%83,425--Mar 31, 2020
VANGUARD INDEX FUNDS0.01%6,195,850-1,838,090-22.88%Mar 31, 2024
ALPS ETF Trust0.01%174,825--Feb 29, 2024
VANGUARD QUANTITATIVE FUNDS0.01%66,56860,7681047.72%Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%36,344--Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.01%549,583-153,727-21.86%Mar 31, 2024
AllianzGI Institutional Multi-Series Trust0.01%1,217-2,148-63.83%Sep 30, 2020
HUSSMAN INVESTMENT TRUST0.01%36,000--Dec 31, 2023
SCHWAB CAPITAL TRUST0.01%413,104--Jan 31, 2024
FIDELITY COVINGTON TRUST0.01%175,160-2,027-1.14%Mar 31, 2024
MML SERIES INVESTMENT FUND0.01%86,701--Dec 31, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%17,707--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.01%154,1042,3281.53%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.01%1,407,066231,73319.72%Feb 29, 2024
PUTNAM ASSET ALLOCATION FUNDS0.01%178,035--Mar 31, 2024
HARTFORD SERIES FUND INC0.01%224,328--Mar 31, 2024
Destra Investment Trust0.00%7,284--Mar 31, 2024
Direxion Shares ETF Trust0.00%629,854--Jan 31, 2024
Calvert Variable Products, Inc.0.00%9,803--Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%33,536--Mar 28, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%102,568-7,725-7.00%Mar 31, 2024
Principal Exchange-Traded Funds0.00%35,5973,57911.18%Mar 31, 2024
GABELLI EQUITY TRUST INC0.00%3,000--Dec 29, 2023
MFS VARIABLE INSURANCE TRUST III0.00%38,929-1,582-3.91%Mar 31, 2024
VANGUARD WORLD FUND0.00%526,1782,7860.53%Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%7,885--Mar 31, 2024
Legg Mason ETF Investment Trust0.00%3,731--Mar 31, 2024
SunAmerica Specialty Series0.00%949--Apr 30, 2021
Voya VARIABLE PORTFOLIOS INC0.00%53,71516,65944.96%Mar 31, 2024
BMO FUNDS, INC.0.00%60,929-6,101-9.10%Nov 30, 2021
Managed Portfolio Series0.00%33,434--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%3,885--Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%45,618--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%816,05227,7903.53%Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%114,1531140.10%Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%6,601--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%1,000--Dec 31, 2023
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%9,500--Mar 28, 2024
DEUTSCHE DWS SECURITIES TRUST0.00%35,000--Jan 31, 2024
OHIO NATIONAL FUND INC0.00%18,515--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%53,8659,80022.24%Mar 31, 2024
SSGA FUNDS0.00%317--Feb 29, 2024
SA FUNDS INVESTMENT TRUST0.00%9,669--Mar 31, 2024
GPS Funds I0.00%2,869--Mar 31, 2024
MAINSTAY VP FUNDS TRUST0.00%54,400--Mar 31, 2024
EQ ADVISORS TRUST0.00%494,291-1,257-0.25%Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%35,796--Mar 31, 2024
FLEXSHARES TRUST0.00%30,072--Jan 31, 2024
NORTHERN FUNDS0.00%54,511-33,116-37.79%Mar 28, 2024
ALLSPRING MASTER TRUST0.00%24,405--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%673,695109,72019.45%Feb 29, 2024
SEASONS SERIES TRUST0.00%7,938--Mar 31, 2024
iSHARES TRUST0.00%5,375,503-529,786-8.97%Mar 31, 2024
RBB FUND, INC.0.00%29,636--Feb 29, 2024
RYDEX SERIES FUNDS0.00%1,314--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%31,492--Feb 29, 2024
Forethought Variable Insurance Trust0.00%1,095--Mar 28, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%13,582--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%29,300-3,700-11.21%Mar 31, 2024
Guggenheim Active Allocation Fund0.00%1,415--Feb 29, 2024
NEW COVENANT FUNDS0.00%1,002--Dec 31, 2023
BLACKROCK FUNDS0.00%1,579,197-95,366-5.69%Feb 29, 2024
Goldman Sachs ETF Trust0.00%22,048-31,562-58.87%Feb 29, 2024
TIAA-CREF FUNDS0.00%657,047--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%27,99410,22657.55%Jan 31, 2024
MAINSTAY FUNDS TRUST0.00%41,833--Jan 31, 2024
VALIC Co I0.00%57,1731,5972.87%Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%25,852-152,550-85.51%Mar 31, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%75,546--Jan 31, 2024
SPDR SERIES TRUST0.00%6,245,136--Mar 31, 2024
Columbia Funds Series Trust II0.00%60,844--Jan 31, 2024

Sangamo Therapeutics's largest mutual fund holder by % of total assets is "Kelly Strategic ETF Trust", owning 101.50K shares, compromising 3.74% of its total assets.

Sangamo Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24119-9.85%
31 Mar, 241320.76%
31 Dec, 23131-2.96%
30 Sep, 23135-11.18%
30 Jun, 23152-16.94%
31 Mar, 23183-2.14%
31 Dec, 22187-6.50%
30 Sep, 222005.26%
30 Jun, 22190-6.86%
31 Mar, 222040.49%
31 Dec, 21203-4.25%
30 Sep, 21212-
30 Jun, 21212-3.20%
31 Mar, 21219-12.05%
31 Dec, 2024911.66%
30 Sep, 202231.36%
30 Jun, 2022011.68%
31 Mar, 20197-3.43%
31 Dec, 192042.00%
30 Sep, 19200-2.91%
30 Jun, 192061.48%
31 Mar, 19203-2.87%
31 Dec, 18209-10.30%
30 Sep, 182333.56%
30 Jun, 182251.35%
31 Mar, 1822218.72%
31 Dec, 1718713.33%
30 Sep, 171651.85%
30 Jun, 1716223.66%
31 Mar, 17131-3.68%
31 Dec, 16136-2.16%
30 Sep, 16139-5.44%
30 Jun, 16147-5.16%
31 Mar, 16155-
31 Dec, 15155-
30 Sep, 15155-8.28%
30 Jun, 15169-6.63%
31 Mar, 151815.23%
31 Dec, 14172-
30 Sep, 141723.61%
30 Jun, 141664.40%
31 Mar, 1415930.33%
31 Dec, 131221.67%
30 Sep, 1312012.15%
30 Jun, 13107148.84%
31 Mar, 134343.33%
31 Dec, 1230-
30 Sep, 1230-9.09%
30 Jun, 123313.79%
31 Mar, 1229-9.38%
31 Dec, 113210.34%
30 Sep, 1129-6.45%
30 Jun, 113114.81%
31 Mar, 112717.39%
31 Dec, 1023-4.17%
30 Sep, 1024-14.29%
30 Jun, 1028-
31 Mar, 10287.69%
31 Dec, 09268.33%
30 Sep, 092414.29%
30 Jun, 09215.00%
31 Mar, 0920-25.93%
31 Dec, 0827-10.00%
30 Sep, 083011.11%
30 Jun, 0827-12.90%
31 Mar, 0831-3.13%
31 Dec, 073277.78%
30 Sep, 0718-5.26%
30 Jun, 0719-
31 Mar, 0719-5.00%
31 Dec, 062011.11%
30 Sep, 061812.50%
30 Jun, 061677.78%
31 Mar, 06950.00%
31 Dec, 056100.00%
30 Sep, 053-50.00%
30 Jun, 05620.00%
31 Mar, 05525.00%
31 Dec, 044-20.00%
30 Sep, 045-16.67%
30 Jun, 046-
31 Mar, 04650.00%
31 Dec, 03433.33%
30 Sep, 033-
30 Jun, 033-
31 Mar, 033-40.00%
31 Dec, 025-16.67%
30 Sep, 026-25.00%
30 Jun, 02814.29%
31 Mar, 02716.67%
31 Dec, 016-14.29%
30 Sep, 017-30.00%
30 Jun, 0110150.00%
31 Mar, 01433.33%
31 Dec, 00350.00%
30 Sep, 002-

As of 30 Jun 24, 119 institutions are holding Sangamo Therapeutics's shares, representing a decrease of -9.85% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2484,528,994-16.27%
31 Mar, 24100,948,72016.17%
31 Dec, 2386,900,000-15.17%
30 Sep, 23102,442,309-3.26%
30 Jun, 23105,891,083-5.66%
31 Mar, 23112,243,4098.03%
31 Dec, 22103,902,0196.80%
30 Sep, 2297,290,2278.57%
30 Jun, 2289,607,53513.43%
31 Mar, 2278,995,3102.79%
31 Dec, 2176,848,1061.49%
30 Sep, 2175,721,271-0.44%
30 Jun, 2176,057,648-4.21%
31 Mar, 2179,403,2961.51%
31 Dec, 2078,221,162-4.11%
30 Sep, 2081,572,5255.89%
30 Jun, 2077,031,8633.42%
31 Mar, 2074,487,619-5.02%
31 Dec, 1978,422,471-4.49%
30 Sep, 1982,113,0602.85%
30 Jun, 1979,838,51421.16%
31 Mar, 1965,897,0403.05%
31 Dec, 1863,946,949-1.23%
30 Sep, 1864,740,6290.02%
30 Jun, 1864,727,47213.20%
31 Mar, 1857,182,0682.40%
31 Dec, 1755,839,7142.19%
30 Sep, 1754,641,4513.02%
30 Jun, 1753,038,93724.48%
31 Mar, 1742,609,2622.80%
31 Dec, 1641,450,039-5.80%
30 Sep, 1644,003,684-4.80%
30 Jun, 1646,220,917-5.28%
31 Mar, 1648,797,132-0.61%
31 Dec, 1549,096,564-6.79%
30 Sep, 1552,670,8234.18%
30 Jun, 1550,555,788-4.15%
31 Mar, 1552,743,6207.28%
31 Dec, 1449,166,0460.70%
30 Sep, 1448,823,639-0.12%
30 Jun, 1448,883,8061.26%
31 Mar, 1448,273,7547.58%
31 Dec, 1344,870,91415.33%
30 Sep, 1338,907,88727.44%
30 Jun, 1330,531,505319.24%
31 Mar, 137,282,61469.67%
31 Dec, 124,292,248-12.76%
30 Sep, 124,920,015-22.30%
30 Jun, 126,332,2858.43%
31 Mar, 125,839,738-7.69%
31 Dec, 116,326,53916.79%
30 Sep, 115,416,967-42.26%
30 Jun, 119,382,33629.87%
31 Mar, 117,224,65353.49%
31 Dec, 104,707,010-21.24%
30 Sep, 105,976,4102.71%
30 Jun, 105,818,613-5.73%
31 Mar, 106,172,2738.60%
31 Dec, 095,683,60916.71%
30 Sep, 094,869,868-1.60%
30 Jun, 094,949,002-14.78%
31 Mar, 095,807,296-44.17%
31 Dec, 0810,401,99139.96%
30 Sep, 087,432,15644.85%
30 Jun, 085,130,834-20.35%
31 Mar, 086,441,918-40.75%
31 Dec, 0710,872,90118.12%
30 Sep, 079,205,06960.94%
30 Jun, 075,719,675267.75%
31 Mar, 071,555,30612.68%
31 Dec, 061,380,305-9.85%
30 Sep, 061,531,155-42.36%
30 Jun, 062,656,348255.87%
31 Mar, 06746,44866.55%
31 Dec, 05448,17560.04%
30 Sep, 05280,037-40.30%
30 Jun, 05469,099170.23%
31 Mar, 05173,59224.69%
31 Dec, 04139,222-19.84%
30 Sep, 04173,678-58.71%
30 Jun, 04420,67865.00%
31 Mar, 04254,96483.34%
31 Dec, 03139,067-32.62%
30 Sep, 03206,402238.75%
30 Jun, 0360,930-63.74%
31 Mar, 03168,053-17.67%
31 Dec, 02204,125-24.81%
30 Sep, 02271,478-44.53%
30 Jun, 02489,3828.57%
31 Mar, 02450,76337.04%
31 Dec, 01328,923-0.30%
30 Sep, 01329,903-38.88%
30 Jun, 01539,73499.69%
31 Mar, 01270,285-56.50%
31 Dec, 00621,317663.76%
30 Sep, 0081,350-

Sangamo Therapeutics (SGMO) has 84.53M shares outstanding as of 30 Jun 24, down -16.27% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2446.87%1.50%
31 Mar, 2455.98%2.34%
31 Dec, 2348.92%1.45%
30 Sep, 2358.03%1.57%
30 Jun, 2360.74%1.37%
31 Mar, 2366.60%1.47%
31 Dec, 2267.32%1.74%
30 Sep, 2262.23%1.70%
30 Jun, 2260.48%2.07%
31 Mar, 2254.03%1.94%
31 Dec, 2152.73%1.94%
30 Sep, 2152.08%1.87%
30 Jun, 2152.82%1.72%
31 Mar, 2155.48%1.82%
31 Dec, 2055.28%1.65%
30 Sep, 2057.81%1.88%
30 Jun, 2055.43%1.35%
31 Mar, 2064.18%1.40%
31 Dec, 1967.66%1.34%
30 Sep, 1970.96%1.46%
30 Jun, 1969.80%1.68%
31 Mar, 1964.43%1.64%
31 Dec, 1862.66%1.55%
30 Sep, 1863.64%1.44%
30 Jun, 1866.55%1.52%
31 Mar, 1866.23%1.30%
31 Dec, 1771.51%1.68%
30 Sep, 1765.24%1.22%
30 Jun, 1773.13%2.03%
31 Mar, 1759.99%1.74%
31 Dec, 1658.75%1.51%
30 Sep, 1662.31%1.45%
30 Jun, 1665.57%1.36%
31 Mar, 1669.34%1.40%
31 Dec, 1570.38%1.24%
30 Sep, 1575.36%1.43%
30 Jun, 1572.55%1.25%
31 Mar, 1576.13%1.41%
31 Dec, 1473.36%1.43%
30 Sep, 1471.56%1.38%
30 Jun, 1471.91%1.23%
31 Mar, 1476.38%1.45%
31 Dec, 1372.52%1.44%
30 Sep, 1371.02%2.20%
30 Jun, 1356.76%30.49%
31 Mar, 1313.64%20.60%
31 Dec, 128.14%9.36%
30 Sep, 129.32%6.45%
30 Jun, 1212.03%9.74%
31 Mar, 1211.11%7.08%
31 Dec, 1112.52%11.75%
30 Sep, 1110.33%3.11%
30 Jun, 1118.22%7.21%
31 Mar, 1115.89%14.70%
31 Dec, 1010.40%5.95%
30 Sep, 1013.22%7.96%
30 Jun, 1012.89%6.86%
31 Mar, 1013.71%7.50%
31 Dec, 0913.52%9.67%
30 Sep, 0911.82%8.16%
30 Jun, 0912.03%6.02%
31 Mar, 0914.14%2.18%
31 Dec, 0825.48%7.73%
30 Sep, 0818.16%11.52%
30 Jun, 0812.56%4.96%
31 Mar, 0815.91%1.88%
31 Dec, 0729.11%5.20%
30 Sep, 0723.65%8.92%
30 Jun, 0716.28%82.71%
31 Mar, 074.44%27.12%
31 Dec, 064.04%19.87%
30 Sep, 064.51%6.27%
30 Jun, 068.48%142.56%
31 Mar, 062.44%81.19%
31 Dec, 051.73%142.94%
30 Sep, 051.10%32.27%
30 Jun, 051.85%393.61%
31 Mar, 050.69%224.95%
31 Dec, 040.55%115.88%
30 Sep, 040.69%24.62%
30 Jun, 041.67%160.66%
31 Mar, 041.02%324.92%
31 Dec, 030.56%81.00%
30 Sep, 030.83%1376.85%
30 Jun, 030.25%53.25%
31 Mar, 030.68%97.83%
31 Dec, 020.83%67.92%
30 Sep, 021.11%27.63%
30 Jun, 022.00%58.46%
31 Mar, 021.85%91.44%
31 Dec, 011.42%77.32%
30 Sep, 011.36%22.87%
30 Jun, 012.44%162.51%
31 Mar, 011.22%15.08%
31 Dec, 002.85%2047.61%
30 Sep, 000.37%-

As of 30 Jun 24, Sangamo Therapeutics is held by 46.87% institutional shareholders, representing a 1.50% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2452-1.89%
31 Mar, 2453-13.11%
31 Dec, 236141.86%
30 Sep, 2343-35.82%
30 Jun, 2367-30.21%
31 Mar, 239618.52%
31 Dec, 2281-14.74%
30 Sep, 22954.40%
30 Jun, 22915.81%
31 Mar, 2286-4.44%
31 Dec, 219012.50%
30 Sep, 2180-1.23%
30 Jun, 2181-5.81%
31 Mar, 2186-25.86%
31 Dec, 2011636.47%
30 Sep, 2085-24.11%
30 Jun, 2011225.84%
31 Mar, 2089-1.11%
31 Dec, 19908.43%
30 Sep, 1983-26.55%
30 Jun, 1911331.40%
31 Mar, 198617.81%
31 Dec, 1873-35.40%
30 Sep, 18113-15.04%
30 Jun, 1813319.82%
31 Mar, 1811113.27%
31 Dec, 179816.67%
30 Sep, 17842.44%
30 Jun, 178257.69%
31 Mar, 1752-10.34%
31 Dec, 1658-3.33%
30 Sep, 166013.21%
30 Jun, 1653-28.38%
31 Mar, 167419.35%
31 Dec, 1562-17.33%
30 Sep, 1575-2.60%
30 Jun, 1577-18.09%
31 Mar, 159422.08%
31 Dec, 14775.48%
30 Sep, 1473-15.12%
30 Jun, 1486-13.13%
31 Mar, 149959.68%
31 Dec, 13623.33%
30 Sep, 1360-28.57%
30 Jun, 1384180.00%
31 Mar, 133057.89%
31 Dec, 121911.76%
30 Sep, 1217-5.56%
30 Jun, 12185.88%
31 Mar, 1217-5.56%
31 Dec, 1118-5.26%
30 Sep, 1119-24.00%
30 Jun, 112547.06%
31 Mar, 111770.00%
31 Dec, 101025.00%
30 Sep, 108-52.94%
30 Jun, 1017-
31 Mar, 1017-10.53%
31 Dec, 091946.15%
30 Sep, 0913-
30 Jun, 091318.18%
31 Mar, 0911-31.25%
31 Dec, 0816-5.88%
30 Sep, 081713.33%
30 Jun, 0815-11.76%
31 Mar, 0817-15.00%
31 Dec, 072081.82%
30 Sep, 0711-
30 Jun, 0711-
31 Mar, 0711-21.43%
31 Dec, 061455.56%
30 Sep, 069-30.77%
30 Jun, 061385.71%
31 Mar, 06740.00%
31 Dec, 055150.00%
30 Sep, 052-50.00%
30 Jun, 054-
31 Mar, 054300.00%
31 Dec, 041-
30 Sep, 04--100.00%
30 Jun, 042-50.00%
31 Mar, 044300.00%
31 Dec, 031-50.00%
30 Sep, 032100.00%
30 Jun, 031-50.00%
31 Mar, 032-33.33%
31 Dec, 023-25.00%
30 Sep, 024-20.00%
30 Jun, 02525.00%
31 Mar, 024-
31 Dec, 014-
30 Sep, 014-50.00%
30 Jun, 018300.00%
31 Mar, 012-33.33%
31 Dec, 00350.00%
30 Sep, 002-

52 institutional shareholders have increased their position in SGMO stock as of 30 Jun 24 compared to 53 in the previous quarter (a -1.89% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2441-16.33%
31 Mar, 244913.95%
31 Dec, 2343-12.24%
30 Sep, 234916.67%
30 Jun, 2342-
31 Mar, 2342-27.59%
31 Dec, 225813.73%
30 Sep, 225110.87%
30 Jun, 2246-20.69%
31 Mar, 2258-3.33%
31 Dec, 2160-11.76%
30 Sep, 2168-5.56%
30 Jun, 2172-
31 Mar, 21729.09%
31 Dec, 2066-5.71%
30 Sep, 207052.17%
30 Jun, 2046-6.12%
31 Mar, 2049-10.91%
31 Dec, 195525.00%
30 Sep, 194412.82%
30 Jun, 1939-23.53%
31 Mar, 1951-34.62%
31 Dec, 187839.29%
30 Sep, 185619.15%
30 Jun, 1847-36.49%
31 Mar, 187451.02%
31 Dec, 174922.50%
30 Sep, 174011.11%
30 Jun, 1736-5.26%
31 Mar, 173815.15%
31 Dec, 163313.79%
30 Sep, 1629-32.56%
30 Jun, 16437.50%
31 Mar, 1640-9.09%
31 Dec, 154415.79%
30 Sep, 1538-17.39%
30 Jun, 15462.22%
31 Mar, 1545-4.26%
31 Dec, 14472.17%
30 Sep, 144635.29%
30 Jun, 1434-
31 Mar, 14349.68%
31 Dec, 133119.23%
30 Sep, 1326188.89%
30 Jun, 13928.57%
31 Mar, 13740.00%
31 Dec, 125-28.57%
30 Sep, 127-12.50%
30 Jun, 12814.29%
31 Mar, 127-30.00%
31 Dec, 1110150.00%
30 Sep, 114300.00%
30 Jun, 111-83.33%
31 Mar, 11650.00%
31 Dec, 104-33.33%
30 Sep, 106100.00%
30 Jun, 103-50.00%
31 Mar, 106100.00%
31 Dec, 093-25.00%
30 Sep, 094-
30 Jun, 09433.33%
31 Mar, 093-57.14%
31 Dec, 08716.67%
30 Sep, 086-25.00%
30 Jun, 08860.00%
31 Mar, 085-44.44%
31 Dec, 079200.00%
30 Sep, 073-25.00%
30 Jun, 074100.00%
31 Mar, 072-
31 Dec, 062-33.33%
30 Sep, 063-
30 Jun, 06--
31 Mar, 06--100.00%
31 Dec, 051-
30 Sep, 05--
30 Jun, 05--
31 Mar, 05--100.00%
31 Dec, 041-50.00%
30 Sep, 042100.00%
30 Jun, 041-
31 Mar, 04--100.00%
31 Dec, 031-
30 Sep, 031-
30 Jun, 031-
31 Mar, 031-50.00%
31 Dec, 022-
30 Sep, 022-
30 Jun, 022100.00%
31 Mar, 021-
31 Dec, 011-66.67%
30 Sep, 013200.00%
30 Jun, 011-
31 Mar, 011-
31 Dec, 00--
30 Sep, 00--

41 institutional shareholders have reduced their position in SGMO stock as of 30 Jun 24 compared to 49 in the previous quarter (a -16.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24119-9.85%84,528,994-16.27%46.87%1.50%52-1.89%41-16.33%
31 Mar, 241320.76%100,948,72016.17%55.98%2.34%53-13.11%4913.95%
31 Dec, 23131-2.96%86,900,000-15.17%48.92%1.45%6141.86%43-12.24%
30 Sep, 23135-11.18%102,442,309-3.26%58.03%1.57%43-35.82%4916.67%
30 Jun, 23152-16.94%105,891,083-5.66%60.74%1.37%67-30.21%42-
31 Mar, 23183-2.14%112,243,4098.03%66.60%1.47%9618.52%42-27.59%
31 Dec, 22187-6.50%103,902,0196.80%67.32%1.74%81-14.74%5813.73%
30 Sep, 222005.26%97,290,2278.57%62.23%1.70%954.40%5110.87%
30 Jun, 22190-6.86%89,607,53513.43%60.48%2.07%915.81%46-20.69%
31 Mar, 222040.49%78,995,3102.79%54.03%1.94%86-4.44%58-3.33%
31 Dec, 21203-4.25%76,848,1061.49%52.73%1.94%9012.50%60-11.76%
30 Sep, 21212-75,721,271-0.44%52.08%1.87%80-1.23%68-5.56%
30 Jun, 21212-3.20%76,057,648-4.21%52.82%1.72%81-5.81%72-
31 Mar, 21219-12.05%79,403,2961.51%55.48%1.82%86-25.86%729.09%
31 Dec, 2024911.66%78,221,162-4.11%55.28%1.65%11636.47%66-5.71%
30 Sep, 202231.36%81,572,5255.89%57.81%1.88%85-24.11%7052.17%
30 Jun, 2022011.68%77,031,8633.42%55.43%1.35%11225.84%46-6.12%
31 Mar, 20197-3.43%74,487,619-5.02%64.18%1.40%89-1.11%49-10.91%
31 Dec, 192042.00%78,422,471-4.49%67.66%1.34%908.43%5525.00%
30 Sep, 19200-2.91%82,113,0602.85%70.96%1.46%83-26.55%4412.82%
30 Jun, 192061.48%79,838,51421.16%69.80%1.68%11331.40%39-23.53%
31 Mar, 19203-2.87%65,897,0403.05%64.43%1.64%8617.81%51-34.62%
31 Dec, 18209-10.30%63,946,949-1.23%62.66%1.55%73-35.40%7839.29%
30 Sep, 182333.56%64,740,6290.02%63.64%1.44%113-15.04%5619.15%
30 Jun, 182251.35%64,727,47213.20%66.55%1.52%13319.82%47-36.49%
31 Mar, 1822218.72%57,182,0682.40%66.23%1.30%11113.27%7451.02%
31 Dec, 1718713.33%55,839,7142.19%71.51%1.68%9816.67%4922.50%
30 Sep, 171651.85%54,641,4513.02%65.24%1.22%842.44%4011.11%
30 Jun, 1716223.66%53,038,93724.48%73.13%2.03%8257.69%36-5.26%
31 Mar, 17131-3.68%42,609,2622.80%59.99%1.74%52-10.34%3815.15%
31 Dec, 16136-2.16%41,450,039-5.80%58.75%1.51%58-3.33%3313.79%
30 Sep, 16139-5.44%44,003,684-4.80%62.31%1.45%6013.21%29-32.56%
30 Jun, 16147-5.16%46,220,917-5.28%65.57%1.36%53-28.38%437.50%
31 Mar, 16155-48,797,132-0.61%69.34%1.40%7419.35%40-9.09%
31 Dec, 15155-49,096,564-6.79%70.38%1.24%62-17.33%4415.79%
30 Sep, 15155-8.28%52,670,8234.18%75.36%1.43%75-2.60%38-17.39%
30 Jun, 15169-6.63%50,555,788-4.15%72.55%1.25%77-18.09%462.22%
31 Mar, 151815.23%52,743,6207.28%76.13%1.41%9422.08%45-4.26%
31 Dec, 14172-49,166,0460.70%73.36%1.43%775.48%472.17%
30 Sep, 141723.61%48,823,639-0.12%71.56%1.38%73-15.12%4635.29%
30 Jun, 141664.40%48,883,8061.26%71.91%1.23%86-13.13%34-
31 Mar, 1415930.33%48,273,7547.58%76.38%1.45%9959.68%349.68%
31 Dec, 131221.67%44,870,91415.33%72.52%1.44%623.33%3119.23%
30 Sep, 1312012.15%38,907,88727.44%71.02%2.20%60-28.57%26188.89%
30 Jun, 13107148.84%30,531,505319.24%56.76%30.49%84180.00%928.57%
31 Mar, 134343.33%7,282,61469.67%13.64%20.60%3057.89%740.00%
31 Dec, 1230-4,292,248-12.76%8.14%9.36%1911.76%5-28.57%
30 Sep, 1230-9.09%4,920,015-22.30%9.32%6.45%17-5.56%7-12.50%
30 Jun, 123313.79%6,332,2858.43%12.03%9.74%185.88%814.29%
31 Mar, 1229-9.38%5,839,738-7.69%11.11%7.08%17-5.56%7-30.00%
31 Dec, 113210.34%6,326,53916.79%12.52%11.75%18-5.26%10150.00%
30 Sep, 1129-6.45%5,416,967-42.26%10.33%3.11%19-24.00%4300.00%
30 Jun, 113114.81%9,382,33629.87%18.22%7.21%2547.06%1-83.33%
31 Mar, 112717.39%7,224,65353.49%15.89%14.70%1770.00%650.00%
31 Dec, 1023-4.17%4,707,010-21.24%10.40%5.95%1025.00%4-33.33%
30 Sep, 1024-14.29%5,976,4102.71%13.22%7.96%8-52.94%6100.00%
30 Jun, 1028-5,818,613-5.73%12.89%6.86%17-3-50.00%
31 Mar, 10287.69%6,172,2738.60%13.71%7.50%17-10.53%6100.00%
31 Dec, 09268.33%5,683,60916.71%13.52%9.67%1946.15%3-25.00%
30 Sep, 092414.29%4,869,868-1.60%11.82%8.16%13-4-
30 Jun, 09215.00%4,949,002-14.78%12.03%6.02%1318.18%433.33%
31 Mar, 0920-25.93%5,807,296-44.17%14.14%2.18%11-31.25%3-57.14%
31 Dec, 0827-10.00%10,401,99139.96%25.48%7.73%16-5.88%716.67%
30 Sep, 083011.11%7,432,15644.85%18.16%11.52%1713.33%6-25.00%
30 Jun, 0827-12.90%5,130,834-20.35%12.56%4.96%15-11.76%860.00%
31 Mar, 0831-3.13%6,441,918-40.75%15.91%1.88%17-15.00%5-44.44%
31 Dec, 073277.78%10,872,90118.12%29.11%5.20%2081.82%9200.00%
30 Sep, 0718-5.26%9,205,06960.94%23.65%8.92%11-3-25.00%
30 Jun, 0719-5,719,675267.75%16.28%82.71%11-4100.00%
31 Mar, 0719-5.00%1,555,30612.68%4.44%27.12%11-21.43%2-
31 Dec, 062011.11%1,380,305-9.85%4.04%19.87%1455.56%2-33.33%
30 Sep, 061812.50%1,531,155-42.36%4.51%6.27%9-30.77%3-
30 Jun, 061677.78%2,656,348255.87%8.48%142.56%1385.71%--
31 Mar, 06950.00%746,44866.55%2.44%81.19%740.00%--100.00%
31 Dec, 056100.00%448,17560.04%1.73%142.94%5150.00%1-
30 Sep, 053-50.00%280,037-40.30%1.10%32.27%2-50.00%--
30 Jun, 05620.00%469,099170.23%1.85%393.61%4---
31 Mar, 05525.00%173,59224.69%0.69%224.95%4300.00%--100.00%
31 Dec, 044-20.00%139,222-19.84%0.55%115.88%1-1-50.00%
30 Sep, 045-16.67%173,678-58.71%0.69%24.62%--100.00%2100.00%
30 Jun, 046-420,67865.00%1.67%160.66%2-50.00%1-
31 Mar, 04650.00%254,96483.34%1.02%324.92%4300.00%--100.00%
31 Dec, 03433.33%139,067-32.62%0.56%81.00%1-50.00%1-
30 Sep, 033-206,402238.75%0.83%1376.85%2100.00%1-
30 Jun, 033-60,930-63.74%0.25%53.25%1-50.00%1-
31 Mar, 033-40.00%168,053-17.67%0.68%97.83%2-33.33%1-50.00%
31 Dec, 025-16.67%204,125-24.81%0.83%67.92%3-25.00%2-
30 Sep, 026-25.00%271,478-44.53%1.11%27.63%4-20.00%2-
30 Jun, 02814.29%489,3828.57%2.00%58.46%525.00%2100.00%
31 Mar, 02716.67%450,76337.04%1.85%91.44%4-1-
31 Dec, 016-14.29%328,923-0.30%1.42%77.32%4-1-66.67%
30 Sep, 017-30.00%329,903-38.88%1.36%22.87%4-50.00%3200.00%
30 Jun, 0110150.00%539,73499.69%2.44%162.51%8300.00%1-
31 Mar, 01433.33%270,285-56.50%1.22%15.08%2-33.33%1-
31 Dec, 00350.00%621,317663.76%2.85%2047.61%350.00%--
30 Sep, 002-81,350-0.37%-2---

Sangamo Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 15, 2024Willoughby Scott B.officer SVP, GEN. COUNSEL & SECRETARYF-InKindSell892$0.98$869.79832,802
Jun 13, 2024Duraibabu Prathyushaofficer SVP, CHIEF FINANCIAL OFFICERF-InKindSell892$0.61$542.07830,528
May 29, 2024Dubois-Stringfellow Nathalieofficer SVP-CHIEF DEVELOPMENT OFFICERF-InKindSell1,787$0.60$1.07K844,401
May 29, 2024Dubois-Stringfellow Nathalieofficer SVP-CHIEF DEVELOPMENT OFFICERF-InKindSell1,508$0.60$904.80842,893

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 15, 2024Willoughby Scott B.officer SVP, GEN. COUNSEL & SECRETARYF-InKindSell892$0.98$869.79832,802
Jun 13, 2024Duraibabu Prathyushaofficer SVP, CHIEF FINANCIAL OFFICERF-InKindSell892$0.61$542.07830,528
Jun 06, 2024Smith Karen L.director-A-AwardBuy25,000--77,100
Jun 06, 2024Smith Karen L.director-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024PARKER H STEWARTdirector-A-AwardBuy25,000--87,600
Jun 06, 2024PARKER H STEWARTdirector-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Meyers James Rdirector-A-AwardBuy25,000--74,600
Jun 06, 2024Meyers James Rdirector-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Markels Johndirector-A-AwardBuy25,000--71,384
Jun 06, 2024Markels Johndirector-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Horn Margaret Adirector-A-AwardBuy25,000--57,650
Jun 06, 2024Horn Margaret Adirector-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Hillan Kenneth J.director-A-AwardBuy25,000--74,600
Jun 06, 2024Hillan Kenneth J.director-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Carey Robertdirector-A-AwardBuy25,000--74,600
Jun 06, 2024Carey Robertdirector-A-AwardBuy50,000$0.57$28.38K50,000
Jun 06, 2024Beers Courtneydirector-A-AwardBuy25,000--57,650
Jun 06, 2024Beers Courtneydirector-A-AwardBuy50,000$0.57$28.38K50,000
May 29, 2024Dubois-Stringfellow Nathalieofficer SVP-CHIEF DEVELOPMENT OFFICERF-InKindSell1,787$0.60$1.07K844,401
May 29, 2024Dubois-Stringfellow Nathalieofficer SVP-CHIEF DEVELOPMENT OFFICERF-InKindSell1,508$0.60$904.80842,893

The last insider sell of Sangamo Therapeutics's stock was made by Willoughby Scott B. on Aug 15 2024, selling 892 shares at $0.98 per share (valued at $869.79).

Sangamo Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-1-
Q2 20241611145.45%
Q1 202451050.00%
Q4 2023-13-
Q3 2023-8-
Q2 20231610160.00%
Q1 2023148175.00%
Q4 202242200.00%
Q3 2022-5-
Q2 20222728.57%
Q1 2022308375.00%
Q4 2021-10-
Q3 20212366.67%
Q2 20212366.67%
Q1 20213116193.75%
Q4 20201520.00%
Q3 202021200.00%
Q2 2020314775.00%
Q1 2020278337.50%
Q4 20194--

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Sangamo Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024---
Q4 2023---
Q3 2023-1-
Q2 2023---
Q1 2023---
Q4 2022---
Q3 2022-4-
Q2 20222--
Q1 2022---
Q4 2021-9-
Q3 2021---
Q2 2021---
Q1 2021-3-
Q4 2020-3-
Q3 2020---
Q2 2020---
Q1 202042200.00%
Q4 2019---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sangamo Therapeutics's stocks.

Sangamo Therapeutics Peer Ownership


TickerCompany
BLUEbluebird bio, Inc.
NTLAIntellia Therapeutics, Inc.
EDITEditas Medicine, Inc.
ALNYAlnylam Pharmaceuticals, Inc.

SGMO Ownership FAQ


Sangamo Therapeutics is owned by institutional shareholders (46.87%), insiders (2.28%), and public (50.85%). The largest institutional shareholder of Sangamo Therapeutics is WASATCH ADVISORS LP (11.14% of total shares) and the top mutual fund owner is Kelly Strategic ETF Trust (3.74% of total shares).

Sangamo Therapeutics's major institutional shareholders are WASATCH ADVISORS LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BLACKROCK INC., and ACADIAN ASSET MANAGEMENT LLC. The top five shareholders own together 30.67% of the company's share outstanding.

As of Jun 2024, there are 119 institutional shareholders of Sangamo Therapeutics.

WASATCH ADVISORS LP owns 20.09M shares of Sangamo Therapeutics, representing 11.14% of the company's total shares outstanding, valued at $7.2M (as of Jun 2024).

As of Jun 2024, ARMISTICE CAPITAL, LLC holds 14.06M shares of Sangamo Therapeutics (SGMO), compromising 7.80% of the company, valued at $5.04M.

VANGUARD GROUP INC is the third largest holder of Sangamo Therapeutics. The company owns 11.9M of the company's shares outstanding (worth $4.26M).